Storage and handling
Other information Protect the product in this container from excessive heat and direct sun
No7 Protect and Perfect Intense Day Cream Sunscreen Broad Spectrum SPF 15
- Manufacturer
- BCM Ltd | The Boots Company PLC
- Effective date
- 2012-12-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:02
Label at a glance#
ProductNo7 Protect and Perfect Intense Day Cream Sunscreen Broad Spectrum SPF 15
Active ingredientAvobenzone, Octocrylene, Octisalate
Label structure17 sections
Contacts and useful links#
Websitewww.boots.com
www.Boots.com
www.Boots.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Avobenzone 3.0%, Octisalate 2%, Octocrylene 4%
Purpose Sunscreen
OTC - PURPOSE SECTION
Uses helps prevent sunburn
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out if eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a poison control center right away.
INDICATIONS & USAGE SECTION
Directons
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Chidren under 6 months of age: Ask a doctor
Sun Protection Measures
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially from 10a,m - 2p.m
wear long-sleeved shirts, pants, hats, and sunglasses
STORAGE AND HANDLING SECTION
Other information
Protect the product in this container from excessive heat and direct sun
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Aqua (water), Glycerin, C12-15 alkyl benzoate, Dimethicone, Cetearryl glucoside, Aluminum starch octenylsuccinate, Tribehenin, Ammonium acryloyldimethyltaurate/VP copolymer, phenoxyethanol, Alcohol denta.,Butyrospermum parkii (shea) butter, Potassium cetyl phosphate, Cetearyl alcohol, Butylene glycol, Dimethiconol, Methylparaben, Parfum (fragrance), Xanthan gum, Ethylparaben, Dipropylene glycol, Retinyl palmitate, Ascorby glucoside, Sodium hyaluronate, Medicago sativa (alfalfa) extract, Tetrasodium EDTA, T-butyl alcohol, Lupinus albus seed extract, Carbomer, Phyllanthus emblica fruit extract, Dimethylmethoxy chromanol, Polysorbate 20, Potassium hydroxide, Ginkgo biloba leaf extract, Ethylhexylglycerin, Simethicone, Tocopherol, Palmitoyl oligopeptide, Palmitoyl tetrapeptide-7
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
Smooth deep lines and wrinkles and help delay new ones with this protecting and renewing daytime formula. Created to answer your skin's needs now and help it have a more youthful-looking future. It is the perfect partner to our Protect and Perfect Intense Serum, formulated to be used together to deliver even better results than the serum alone.
INFORMATION FOR PATIENTS SECTION
The Boots Company PLC Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UKwww.Boots.com
DESCRIPTION SECTION
For best results: After cleansing, simply smooth into your face and neck with your fingertips, avoiding your eyes.
With our skin firming pro-retinol complex containing Lipopeptides and Alfalfa extract that works to help restore the skin's structure and maintain elasticity.
Jar
Active ingredients: Avobenzone 3%, Octisalate 2.%, Octocrylene 4%
warning
JAR TEXT
Warning: Avoid contact with eyes. If product gets into the eyes rinse well with water immediately.
DESCRIPTION SECTION
JAR TEXT
Smooth into your face and neck after applying your No7 serum.
INFORMATION FOR PATIENTS SECTION
JAR TEXT
The Boots Company PLC
Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc.
Norwalk CT 06851 USA
Made in the UKwww.Boots.com
carton
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11489-077-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-eba5-f424-e053-dadaa90a57ce | No7 Protect and Perfect Intense Day Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11489-077-01 | No7 Protect and Perfect Intense Day Cream Sunscreen Broad Spectrum SPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 11489-077-01 | No7 Protect and Perfect Intense Day Cream Sunscreen Broad Spectrum SPF 15 | 50 g in 1 JAR | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11489-077 | NO7 PROTECT AND PERFECT INTENSE DAY CREAM SUNSCREEN BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE, OCTOCRYLENE) CREAM [BCM LTD] | 1 | Legacy NDC, 2 package rows | 20121220_c240b646-9d43-498e-9d30-3bba4ea78b94.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ALFALFA | INACTIVE INGREDIENT | DJO934BRBD | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALUMINUM STARCH OCTENYLSUCCINATE | INACTIVE INGREDIENT | I9PJ0O6294 | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| Butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| ginkgo | INACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| LUPINUS ALBUS SEED | INACTIVE INGREDIENT | 24GB753W3B | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PHYLLANTHUS EMBLICA FRUIT | INACTIVE INGREDIENT | YLX4CW2576 | 1 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| potassium hydroxide | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| Tribehenin | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Protect and Perfect Intense Day Cream Sunscreen Broad Spectrum SPF 15
- Avobenzone, Octisalate, Octocrylene
- Avobenzone
- Octocrylene
- Octisalate
- Water
- Glycerin
- ALKYL (C12-15) BENZOATE
- Dimethicone
- CETEARYL GLUCOSIDE
- ALUMINUM STARCH OCTENYLSUCCINATE
- Tribehenin
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- Phenoxyethanol
- Alcohol
- SHEA BUTTER
- POTASSIUM CETYL PHOSPHATE
- CETOSTEARYL ALCOHOL
- Butylene glycol
- methylparaben
- Xanthan gum
- ETHYLPARABEN
- DIPROPYLENE GLYCOL
- VITAMIN A PALMITATE
- ASCORBYL GLUCOSIDE
- HYALURONATE SODIUM
- ALFALFA
- EDETATE SODIUM
- TERT-BUTYL ALCOHOL
- LUPINUS ALBUS SEED
- PHYLLANTHUS EMBLICA FRUIT
- polysorbate 20
- potassium hydroxide
- ginkgo
- ethylhexylglycerin
- tocopherol
- PALMITOYL OLIGOPEPTIDE
- PALMITOYL TETRAPEPTIDE-7
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11489-077 | 11489-077-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Butylene glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUPPOSITORY / VAGINAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / TOPICAL | 0.24 %w/v | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| TERT-BUTYL ALCOHOL | TERT-BUTYL ALCOHOL | MD83SFE959 | GEL / TOPICAL | 0.12 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / ORAL | ADJ PH | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET / ORAL | 1.8 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| Xanthan gum | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0fbaa8b8-2137-423e-8f59-e2057d75e2cb | c240b646-9d43-498e-9d30-3bba4ea78b94 | 2012-12-18 | Warnings | 0fbaa8b8-2137-423e-8f59-e2057d75e2cb c240b646-9d43-498e-9d30-3bba4ea78b94 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.